UCF-101, a Novel Omi/HtrA2 inhibitor, protects against cerebral ischemia/reperfusion injury in rats

Anatomical Record

Volumn 292, Issue 6, 2009, Pages 854-861

  Su, Danying ^a   Su, Zhiqiang ^a   Wang, Jiaye ^a   Yang, Shanshan ^a   Ma, Jing ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia reperfusion; FLIP; Neuroprotection; Omi HtrA2; UCF 101

Indexed keywords

CASPASE 3; CASPASE 8; FAS LIGAND; FLICE INHIBITORY PROTEIN; SERINE PROTEINASE INHIBITOR; UCF 101; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; MALE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; UPREGULATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN ISCHEMIA; CASPASE 3; CASPASE 8; CEREBRAL INFARCTION; ENZYME INHIBITORS; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MITOCHONDRIAL PROTEINS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; PYRIMIDINONES; RATS; RATS, WISTAR; REPERFUSION INJURY; RNA-BINDING PROTEINS; SERINE ENDOPEPTIDASES; THIONES;

ANIMALIA; MUS; RATTUS; RATTUS NORVEGICUS;

EID: 67651159201     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20910     Document Type: Article

References (40)

1. Althaus J, Siegelin MD, Dehghani F, Cilenti L, Zervos AS, Rami A. 2007. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion. Neurochem Int 50:172-180.
2. Ashkenazi A. 2002. Targeting death and decoy receptors of the tumour necrosis factor superfamily. Nat Rev Cancer 2:420-430. Bannerman DD, Eiting KT, Winn RK, Harlan JM. 2004. Flice-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kB activation induced by bacterial lipopolysaccharide. Am J Pathol 165:1423-1431.
3. Bhuiyan MS, Fukunaga K. 2007. Inhibition of HtrA2/Omi ameliorates heart dysfuction following ischemia/reperfusion injury in rat heart in vivo. Eur J Pharmacol 557:168-177.
4. Bi FF, Xiao B, Hu YQ, Tian FF, Wu ZG, Ding L, Zhou XF. 2008. Expression and localization of Fas-associated proteins following focal cerebral ischemia in rats. Brain Res 1191:30-38
5. Choi DW. 1996. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 6:667-672. Cilenti L, Kyriazis GA, Soundarapandian MM, Stratico V, Yerkes A,
6. Park KM, Sheridan AM, Alnemri ES, Bonventre JV, Zervos AS. 2005. Omi/ HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am J Physiol Renal Physiol 288:F371-F379.
7. Cilenti L, Lee Y, Hess S, Srinivasula S, Park KM, Junqueira D, Davis H, Bonventre JV, Alnemri ES, Zervos AS. 2003. Characterization of a novel and specific inhibitor for the pro-apoptotic protease HtrA2/Omi. J Biol Chem 278:11489-11494.
8. Hegde R, Srinivasula SM, Zhang Z, Wassell R, Cilenti L, DuBois G, Lazebnik Y, Zervos AS, Fernandes-Alnemri T, Alnemri ES. 2002. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitors of apoptosis proteincaspase interaction. J Biol Chem 277:432-438.
9. Igney FH, Krammer PH. 2002. Death and anti-death:tumour resistance to apoptosis. Nat Rev Cancer 2:277-288.
10. Jin K, Graham SH, Mao X, Nagayama T, Simon RP, Greenberg DA. 2001. Fas (CD95) may mediate delayed cell death in hippocampal CA1 sector after global cerebral ischemia. J Cereb Blood Flow Metab 21:1411-1421.
11. Kitsberg D, Formstecher E, Fauquet M, Kubes M, Cordier J, Canton B, Pan G, Rolli M, Glowinski J, Chneiweiss H. 1999. Knockout of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNF-induced apoptosis. J Neurosci 19:8244-8251.
12. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S. 2001. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 276:20633-20640.
13. Kumar S, Vaux DL. 2002. APOPTOSIS:A Cinderella caspase takes center stage. Science 297:1290-1291.
14. Lei B, Popp S, Capuano-waters C, Cottrell JE, Kass IS. 2004. Lidocaine attenuates apoptosis in the ischemic penumbra and reduces infarct size after transient focal cerebral ischemia in rats. Neuroscience 125:691-701.
15. Li W, Srinivasula SM, Chai J, Li P, Wu JW, Zhang Z, Alnemri ES, Shi Y. 2002. Structural insights into the proapoptotic function of mitochondrial serine protease HtrA2/Omi. Nat Struct Biol 9: 436-441.
16. Li Y, Chopp M, Jiang N, Zaloga C. 1995. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 15:389-397.
17. Li Y, Zhou C, Calvert JW, Colohan ART, Zhang JH, 2005. Multiple effects of hyperbaric oxygen on the expression of HIF-1 alpha and apoptotic genes in a global ischemia-hypotension rat model. Exp Neurol 191:198-210.
18. Liu HR, Gao E, Hu A, Tao L, Qu Y, Most P, Koch WJ, Christopher TA, Longa EZ, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.
19. Lopez BL, Alnemri ES, Zervos AS, Ma XL. 2005. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion. Circulation 111:90-96.
20. Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR, Savopoulos J, Gray CW, Creasy CL, Dingwall C,
21. Downward J. 2002. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 277:439-444.
22. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH. 2001. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 8:679-686.
23. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM. 1999. CD95 ligand (FasL/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 19:3809-3817.
24. Matsumori Y, Northington FJ, Hong SM, Kayama T, Sheldon RA, vexler ZS, Ferriero DM, Weinstein PR, Liu J. 2006. Reduction of Caspase-8 and -9 cleavage is associated with increased c-FLIP and increased binding of Apaf-1 and Hsp70 after neonatal hypoxic/ischemic injury in mice overexpressing Hsp70. Stroke 37:507-512.
25. Murakami K, Kondo T, Chan PH. 1997. Reperfusion following focal cerebral ischemia alters distribution of neuronal cells with DNA fragmentation in mice. Brain Res 751:160-164.
26. Nagata S. 1997. Apoptosis by death factor. Cell 88:355-365. Nakka VP, Gusain A, Mehta SL, Raghubir R. 2008. Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol Neurobiol 37:7-38.
27. Noto T, Ishiye M, Furuich Y, Keida Y, Katsuta K, Moriguchi A, Matsuoka N, Aramori I, Goto T, Yanagihara T. 2004. Neuroprotective effect of tacrolimus (FK506) on ischemic brain damage following permanent focal cerebral ischemia in the rat. Brain Res Mol Brain Res 128:30-38.
28. Ni B, Wu X, Su Y, Stephenson D, Smalstig EB, Clemens J, Paul SM. 1998. Transient global forebrain ischemia induces a prolonged expression of the caspase-3 MRNA in rat hippocampal CA1 pyramidal neurons. J Cereb Blood Flow Metab 18:248-256.
29. Peter ME, Krammer PH. 2003. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ 10:26-35.
30. Sairanen T, Karjalainen-Lindsberg ML, Paetau A, Ijäs P, Lindsberg PJ. 2006. Apoptosis dominant in the periinfarct area of human ischemic stroke-a possible target of antiapoptotic treatments.Brain 129:189-199.
31. Scaffidi C, Schmitz I, Krammer PH, Peter ME. 1999. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274:1541-1548.
32. Song JH, Bellail A, Tse MCL, Yong VW, Hao C. 2006. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. J Neurosci 26:3299-3308.
33. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. 2001. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, including cell death. Mol Cell 8:613-621.
34. Taoufik E, Valable S, Müller GJ, Roberts ML, Divoux D, Tinel A, Voulgari-Kokota A, Tseveleki V, Altruda F, Lassmann H, Petit E, Probert L. 2007. FLIP (L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. J Neurosci 27:6633-6646.
35. Trencia A, Fiory F, Maitan MA, Vito P, Barbagallo AP, Perfetti A, Miele C, Ungaro P, Oriente F, Cilenti L, Zervos AS, Formisano P,
36. Beguinot F. 2004. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15. J Biol Chem 279:46566-46572.
37. Tschopp J, Irmler M, Thome M. 1998. Inhibition of fas death signals by FLIPs. Curr Opin Immunol 10:552-558.
38. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ, Vaux DL. 2002. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277:445-454.
39. Xu XS, Chua CC, Gao JP, Hamdy RC, Chua BHL. 2006. Humanin is a novel neuroprotective agent against Stroke. Stroke 37:2613-2619.
40. Yao H, Takasawa R, Fukuda K, Shiokawa D, Sadanaga-Akiyoshi F, Ibayashi S, Tanuma S-l, Uchimura H. 2001. DNA fragmentation in ischemic core and penumbra in focal cerebral ischemia in rats. Mol Brain Res 91:112-118